Cas13d-based nanotherapy targeting undruggable transcription factor HoxB13 to inhibit prostate cancer metastasis
Research Grant
Administered By
Pathology
Awarded By
North Carolina Biotechnology Center
Start Date
July 1, 2023
End Date
June 30, 2025
Administered By
Pathology
Awarded By
North Carolina Biotechnology Center
Start Date
July 1, 2023
End Date
June 30, 2025